CHARLESTON, S.C.--(BUSINESS WIRE)--SCRA’s Technology Ventures sector, which manages the commercialization and economic development program SC Launch, today announced a partnership between two SC Launch client companies. Lab21 Limited, a global specialist in personalized medicine and diagnostics, has licensed the use of Cooperative Diagnostics’ suite of patents and expertise. The use of these licenses will further the development of molecular diagnostic clinical procedures to test or measure the activity and potential impacts of drugs in humans.
